Tuesday December 11, 2018

Erectile Dysfunction Causes cardiovascular risk among middle-aged men.

The researchers examined more than 1,900 men, aged between 60 to 78.

0
//
Erectile Dysfunction Causes cardiovascular risk among middle-aged men.
Erectile Dysfunction Causes cardiovascular risk among middle-aged men., Flickr
Republish
Reprint

Erectile dysfunction (ED) indicates greater cardiovascular risk, regardless of other risk factors, such as cholesterol, smoking and high blood pressure, researchers warn.

The findings, published in the journal Circulation, suggest that ED is an important telltale sign that can help physicians gauge cardiovascular risk among middle-aged men.

The researchers found that, among the participants of the study carried over four years, those who reported ED were twice as likely to experience heart attacks, cardiac arrests, sudden cardiac death and fatal or non-fatal strokes.

“Our results reveal that erectile dysfunction is, in and of itself, a potent predictor of cardiovascular risk,” said co-author Michael Blaha, Associate Professor at the Johns Hopkins University School of Medicine in Baltimore.

Human cardiovascular system
Human cardiovascular system, pixabay

According to the research, ED — defined as the inability to achieve or maintain an erection for satisfactory sexual intercourse — affects nearly 20 per cent of men over age 20.

Cardiovascular disease and ED share common risk factors, including obesity, hypertension, smoking, diabetes and metabolic syndrome — a condition marked by a cluster of features such as elevated blood sugar, hypertension and excess abdominal fat.

For the study, the researchers examined more than 1,900 men, aged between 60 to 78.

During the four-year follow-up, there were a total of 115 fatal and non-fatal heart attacks, fatal and non-fatal strokes, cardiac arrests and sudden cardiac deaths, the researchers said.

A greater proportion of men who reported ED (6.3 per cent) suffered heart attacks, cardiac arrests or strokes than men who didn’t report ED (2.6 per cent), they added.

A middle aged men
A middle aged men, Pixabay

When the researchers adjusted their analysis to eliminate the potential influence of other risk factors, that risk was somewhat lessened but still markedly higher — men with ED were nearly twice as likely to suffer cardiovascular events than men without ED.

Also read: baby turtle turns into a male

Limited evidence of a link between ED and cardiovascular disease has emerged over the last several years, but results of this latest study provide what researchers say is the strongest indication to date that sexual dysfunction indicates heightened cardiovascular risk, the researchers noted.(IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Drug Used For Osteoporosis May Help in Reducing Heart Attack Risk

Intake of the drug also reduced the risk of stroke by 18 per cent within five years and 17 per cent within 10 years.

0
A commonly used drug for treating osteoporosis or bone pain may also help reduce the risk of death by cardiovascular, heart attack and stroke, according to a study.
Heart Attack risk can be decreased by drug of osteoporosis, Pixabay

A commonly used drug for treating osteoporosis or bone pain may also help reduce the risk of death by cardiovascular, heart attack and stroke, according to a study.

The report, published in Journal of Bone and Mineral Research, showed that the drug Alendronate could lower the risk of cardiovascular diseases by 67 per cent and heart attacks by 45 per cent within a year.

Intake of the drug also reduced the risk of stroke by 18 per cent within five years and 17 per cent within 10 years.

“Our findings show that Alendronate is potentially cardioprotective in hip fracture patients,” said Ching-Lung Cheung, from the University of Hong Kong.

“Physicians should consider prescribing Alendronate or other similar drugs to patients with hip fracture and patients should also have good compliance with Alendronate treatment, as this is not only good for your bones but also your heart,” Cheung added.

It is used for osteoporosis, osteogenesis imperfecta, and several other bone diseases.
Spine Bones, Pixabay

Alendronate belongs to a class of drugs called bisphosphonates and works by preventing bone breakdown and increasing bone density.

It is used for osteoporosis, osteogenesis imperfecta, and several other bone diseases.

The researchers collected data from 34,991 patients, diagnosed with hip fracture in 2005. Out of these 4,602 patients received osteoporosis treatment during follow up.

Also Read: Healthy Diet May Decrease the Risk of Hearing Loss in Women 

Due to excess cardiovascular adverse events, there is a worldwide crisis in the current treatment of osteoporosis with drug romosozumab.

In 2017, the US Food and Drug Administration (FDA) had rejected romosozumab and requested more data before reaching a decision.

The study, thus, has significant implications in clinical trial design of anti-osteoporosis medications, the researchers said. (IANS)